Regulation 2

In these Regulations, unless the context otherwise requires —“AI Regulations” means the Health Products (Active Ingredients) Regulations 2023 (G.N. No. S 831/2023);“clinical research material” has the meaning given by regulation 2(1) of the CRM Regulations;“CP-ACD Regulations” means the Health Products (Cosmetic Products — ASEAN Cosmetic Directive) Regulations 2007 (G.N. No. S 683/2007);“CRM Regulations” means the Health Products (Clinical Research Materials) Regulations 2016 (G.N. No. S 332/2016);“CTGT product” means a health product categorised as a cell, tissue or gene therapy product in the First Schedule to the Act;“CTGTP Regulations” means the Health Products (Cell, Tissue and Gene Therapy Products) Regulations 2021 (G.N. No. S 104/2021);“GMPC-CP Regulations” means the Health Products (Good Manufacturing Practice Certificate — Cosmetic Products) Regulations 2011 (G.N. No. S 543/2011);“LRP Regulations” means the Health Products (Licensing of Retail Pharmacies) Regulations 2016 (G.N. No. S 330/2016);“MD Regulations” means the Health Products (Medical Devices) Regulations 2010 (G.N. No. S 436/2010);“medical device” means a health product categorised as a medical device in the First Schedule to the Act;“ODG Regulations” means the Health Products (Oral Dental Gums) Regulations 2016 (G.N. No. S 539/2016);“oral dental gum” means a health product categorised as an oral dental gum in the First Schedule to the Act;“retail pharmacy” has the meaning given by regulation 2 of the LRP Regulations;“therapeutic product” means a health product categorised as a therapeutic product in the First Schedule to the Act;“TP Regulations” means the Health Products (Therapeutic Products) Regulations 2016 (G.N. No. S 329/2016).